Oral Ozempic Pill: How It Works and What It Costs
A new oral semaglutide pill launched in 2026 offers a more affordable alternative to injectable Ozempic — here’s what the research shows.
Oral Ozempic Pill: How It Works and What It Costs Read More »
Latest medical research, clinical studies, and health discoveries
A new oral semaglutide pill launched in 2026 offers a more affordable alternative to injectable Ozempic — here’s what the research shows.
Oral Ozempic Pill: How It Works and What It Costs Read More »
New NIH research finds testosterone may suppress glioblastoma growth — men on supplements showed 38% lower risk of death. Here’s what the science reveals.
Testosterone May Slow Brain Tumor Growth, NIH Study Finds Read More »
A new NIH-funded AI model called scSurvival can predict cancer survival outcomes by analyzing individual tumor cells — a potential breakthrough for melanoma and liver cancer.
AI Model Predicts Cancer Survival from Tumor Cell Data Read More »
Low vitamin D levels may raise your risk of cognitive decline and Alzheimer’s. Here’s what the latest research reveals about protecting your brain.
Vitamin D and Brain Health: What the Research Reveals Read More »
A new NIH-backed trial found semaglutide cut heavy drinking days by 41% — could GLP-1 drugs become the next breakthrough for alcohol use disorder?
GLP-1 Drugs May Curb Alcohol Cravings, New Trial Finds Read More »
A 2026 study finds fish oil EPA may impair brain repair after head injuries. Here’s what it means — and doesn’t — for your omega-3 routine.
Fish Oil and Brain Repair: What New Research Reveals Read More »
Millions take daily aspirin without a prescription. But major clinical trials and USPSTF guidelines tell a different story. What does science show?
Daily Aspirin: 7 Common Myths, Finally Debunked Read More »
Mammography guidelines have shifted. Here’s what major organizations recommend about when to start, how often, and what your risk factors mean.
Mammography Screening: What New Guidelines Mean for You Read More »
NIH researchers discovered DFNZ, a synthetic opioid that relieves severe pain without addiction, dependency, or withdrawal — a potential breakthrough.
A Powerful Pain Reliever With No Addiction Risk? Read More »
NIH-funded researchers engineered a miniaturized CRISPR enzyme that fits inside viral delivery vehicles, achieving 80%+ editing efficiency for cancer and ALS targets.
Smaller CRISPR Tool Shows Promise for Cancer and ALS Read More »